Press Release
« Back
Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference
Jun 6, 2017
The live webcast will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for seven days following the event.
About
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes antibodies, antibody-drug conjugates and other protein-based therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Visit www.celldex.com.
Company ContactSource:Sarah Cavanaugh Vice President of Investor Relations& Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldex.comCharles Liles Associate Director of Investor Relations& Corp Communications Celldex Therapeutics, Inc. (781) 433-3107 cliles@celldex.com
News Provided by Acquire Media